داروسازیزهراوی
دزهراوی | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 5,280 2.92
Close Price: 5,280
Balance Sheet
AGM
Interim
2026/06/20 Fiscal Year 2026/03/2012 Month | 2025/05/03 Fiscal Year 2025/03/2012 Month | 2024/07/09 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 693.406 Billion | 230.293 Billion | 202.319 Billion | |
Trade Receivables | 11.11 Trillion | 5.211 Trillion | 4.298 Trillion | |
Prepayments | 481.054 Billion | 445.832 Billion | 339.528 Billion | |
Raw Materials & Packaging Inventory | 1.691 Trillion | 1.105 Trillion | 877.829 Billion | |
Work-in-Progress Inventory | 163.95 Billion | 29.654 Billion | 49.27 Billion | |
Finished Goods Inventory | 232.784 Billion | 247.274 Billion | 444.323 Billion | |
Spare Parts Inventory | 105.72 Billion | 94.779 Billion | 94.331 Billion | |
Goods in Transit | 4.312 Billion | - | - | |
Our Goods on Consignment with Others | 15.698 Billion | 17.463 Billion | 21.321 Billion | |
Other Inventories | - | - | -36.467 Billion | |
Inventories | 2.214 Trillion | 1.494 Trillion | 1.451 Trillion | |
Total Current Assets | 14.499 Trillion | 7.381 Trillion | 6.29 Trillion | |
Long-Term Investments | 22.898 Billion | 5.006 Billion | 5.006 Billion | |
Intangible Assets | 72.02 Billion | 31.828 Billion | 32.72 Billion | |
Other Assets | 338.029 Billion | 348.346 Billion | 355.626 Billion | |
Property, Plant & Equipment | 10.295 Trillion | 10.172 Trillion | 10.3 Trillion | |
Net Fixed Assets | 10.295 Trillion | 10.172 Trillion | 10.3 Trillion | |
Total Non-Current Assets | 10.728 Trillion | 10.557 Trillion | 10.693 Trillion | |
Total Assets | 25.227 Trillion | 17.938 Trillion | 16.983 Trillion | |
Trade Payables | 5.037 Trillion | 3.634 Trillion | 2.675 Trillion | |
Advances Received | 199.127 Billion | 116.751 Billion | 34.947 Billion | |
Income Tax Provision | 1.216 Trillion | 675.374 Billion | 689.284 Billion | |
Other Provisions | 48.706 Billion | 29.761 Billion | 36.215 Billion | |
Proposed & Payable Dividends | 275.669 Billion | 95.525 Billion | 95.525 Billion | |
Current Borrowings | 3.445 Trillion | 1.469 Trillion | 1.755 Trillion | |
Total Current Liabilities | 10.221 Trillion | 6.021 Trillion | 5.286 Trillion | |
Long-Term Borrowings | - | - | 363.366 Billion | |
Employee Termination Benefits Provision | 267.855 Billion | 157.276 Billion | 32.376 Billion | |
Total Non-Current Liabilities | 1.114 Trillion | 1.068 Trillion | 1.307 Trillion | |
Total Liabilities | 11.335 Trillion | 7.089 Trillion | 6.593 Trillion | |
Capital | 10.634 Trillion | 3.204 Trillion | 3.204 Trillion | |
Retained Earnings | 3.11 Trillion | 232.072 Billion | -248.525 Billion | |
Legal Reserve | 196.123 Billion | 36.214 Billion | 24 Billion | |
Share Premium Reserve | -48.267 Billion | -52.647 Billion | -18.41 Billion | |
Total Equity | 13.892 Trillion | 10.849 Trillion | 10.391 Trillion | |
Total Liabilities & Equity | 25.227 Trillion | 17.938 Trillion | 16.983 Trillion | |
Approved Capital | 10.634 Trillion | 3.204 Trillion | 3.204 Trillion | |
Approved Retained Earnings | 1.558 Trillion | 71.872 Billion | -248.525 Billion | |
Approved Legal Reserve | 196.123 Billion | 36.214 Billion | 24 Billion | |
Total Approved Equity (at AGM) | 12.388 Trillion | 3.312 Trillion | 2.979 Trillion | |
درآمد انتقالی به دورههای آتی | 845.858 Billion | 910.788 Billion | 910.788 Billion | |
Revaluation Surplus of Property, Plant and Equipment | - | 7.43 Trillion | 7.43 Trillion |